Global /United States /Healthcare /Biotechnology /ALT

Altimmune, Inc.

ALT

• NASDAQ: ALT • Delayed

2.63USD -4%

As of 13 June 2026, Altimmune, Inc. has a market cap of $510.74M USD, ranking #14986 globally and #2616 in the United States. It ranks #1333 in the Healthcare sector, and #251 in the Biotechnology industry.

Global Rank

14986

Country Rank

2616

Sector Rank

1333

Industry Rank

251

Key Stats

Market Cap

$510.74MUSD

Enterprise Value

$271.03MUSD

Revenue (TTM)

$41.0KUSD

EBITDA (TTM)

-$94.38MUSD

Net Income (TTM)

-$88.09MUSD

PS Ratio

12409.8

PB Ratio

1.3

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Biotechnology

CEO

Jerome Durso open_in_new

Employees

Founded

1997

Website

altimmune.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4%	-24%	-13%	-49%	-35%	-27%	-48%	-48%	-81%

News

ALT Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	ALT Altimmune Inc ISIN: US02155H2004 Shares Out.: Shares Outstanding: 194.474M¹ Shares Float: 183.668M² TV: TradingView: NASDAQ: ALT SA: Stock Analysis: NASDAQ: ALT YF: Yahoo Finance: ALT GF: Google Finance: NASDAQ: ALT NQ: NASDAQ: ALT BA: Barron's: ALT MS: Morningstar: XNAS: ALT	2.63 USD	TV: TradingView: NASDAQ: ALT SA: Stock Analysis: NASDAQ: ALT YF: Yahoo Finance: ALT GF: Google Finance: NASDAQ: ALT NQ: NASDAQ: ALT BA: Barron's: ALT MS: Morningstar: XNAS: ALT
London Stock Exchange (LSE / LON) MIC: XLON	0A4C Altimmune Inc ISIN: US02155H2004 Shares Out.: Shares Outstanding: 104.342M¹ Shares Float: 103.606M² TV: TradingView: LSE: 0A4C SA: Stock Analysis: LON: 0A4C YF: Yahoo Finance: 0A4C.L GF: Google Finance: LON: 0A4C BA: Barron's: 0A4C MS: Morningstar: XLON: 0A4C	5.39 USD	TV: TradingView: LSE: 0A4C SA: Stock Analysis: LON: 0A4C YF: Yahoo Finance: 0A4C.L GF: Google Finance: LON: 0A4C BA: Barron's: 0A4C MS: Morningstar: XLON: 0A4C
Frankfurt Stock Exchange (FRA) MIC: XFRA	3G0 Altimmune Inc ISIN: US02155H2004 TV: TradingView: FWB: 3G0 SA: Stock Analysis: FRA: 3G0 YF: Yahoo Finance: 3G0.F GF: Google Finance: FRA: 3G0 BA: Barron's: 3G0 MS: Morningstar: XFRA: 3G0	2.33 EUR	TV: TradingView: FWB: 3G0 SA: Stock Analysis: FRA: 3G0 YF: Yahoo Finance: 3G0.F GF: Google Finance: FRA: 3G0 BA: Barron's: 3G0 MS: Morningstar: XFRA: 3G0
Mexican Bolsa (BMV) MIC: XMEX	ALT1 Altimmune Inc ISIN: US02155H2004 TV: TradingView: BMV: ALT1 SA: Stock Analysis: BMV: ALT1 YF: Yahoo Finance: ALT1.MX GF: Google Finance: BMV: ALT1 BA: Barron's: ALT1 MS: Morningstar: XMEX: ALT1	45.09 MXN	TV: TradingView: BMV: ALT1 SA: Stock Analysis: BMV: ALT1 YF: Yahoo Finance: ALT1.MX GF: Google Finance: BMV: ALT1 BA: Barron's: ALT1 MS: Morningstar: XMEX: ALT1

Show all 4 markets

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Altimmune, Inc.

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Similar Companies

Industry: Biotechnology (United States)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 36K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 31K%	19.0	United States
Natera, Inc. NASDAQ: NTRA	$27.6B 5K%	-	United States
IQVIA Holdings Inc. NYSE: IQV	$26.3B 5K%	20.0	United States
United Therapeutics Corp. NASDAQ: UTHR	$25.03B 5K%	20.4	United States
Moderna, Inc. NASDAQ: MRNA	$18.13B 3K%	-	United States

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
argenx SE EBR: ARGX	$47.84B 41.39B EUR 9K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 9K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 8K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 8K%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 5K%	43.8	South Korea
BioNTech SE NASDAQ: BNTX	$25.69B 5K%	-	Germany

chevron_leftBack